Table 2 Sequences of oligonucleotides used in the present study
Oligonucleotides | |
|---|---|
Wdr63 | Forward 5′-GAGAGGGTCCACTTTTCGGG-3′ |
Reverse 5′-GGCAGCCAGTGTATGTCTGT-3′ | |
Fank1 | Forward 5′-TCGATCGGCAGATACCACAG-3′ |
Reverse 5′-CCCAAGAAGCTCCGTGTCTT-3′ | |
Fgf9 | Forward 5′-ACGAGAAGGGGGAGCTGTAT-3′ |
Reverse 5′-CGGGTCCACTGGTCTAGGTA-3′ | |
Adam8 | Forward 5′-CATCAGACTCTTGCTTTGCC-3′ |
Reverse 5′-AAACCTTCCCCTCCTCACAC-3′ | |
SerpinB10 | Forward 5′-AGAACTTGCATCCTCCAGAAA-3′ |
Reverse 5′-CTGCGGTTCTGCACCAAAAT-3′ | |
Cdkn2a | Forward 5′-ACAGTATCTACGTGCGGCTG-3′ |
Reverse 5′-TGTCTGGGCAGAAGTTACGC-3′ | |
Cdkn1a | Forward 5′-AGCGATATTGTTCGGAGGCA-3′ |
Reverse 5′-CACTTTGCTCCTGTGTGGGA-3′ | |
Bcl2 | Forward 5′-CTTTGAGTTCGGTGGGGTCA-3′ |
Reverse 5′-GGTCGGTGAACCTCACTTGT-3′ | |
Ace2 | Forward 5′-CTGGGAAAACTCCATGCTG-3′ |
Reverse 5′-GAACGATCTCTCGCTTCATCT-3′ | |
Tmprss2 | Forward 5′-GGGCTACGAGCTTTATGAAGC-3′ |
Reverse 5′-GGACGAACAGGAGTCACTGTG-3′ | |
Ctsl | Forward 5′-GGGTGATGTCCCCAAGTCTG-3′ |
Reverse 5′-TGGCCACAGCCTTCATTAGG-3′ | |
Nrp1 | Forward 5′-CTGGAAAGAAGGGCGTGTCT-3′ |
Reverse 5′-CTTCATATCCGGGGGTGCTC-3′ | |
Ifnb | Forward 5′-ACCCTAAAGGAAGTGCCAG-3′ |
Reverse 5′-CCAGCTGCCAGTAATAGCTC-3′ | |
Ifnl | Forward 5′-CCCACCAGATGCAAAGGATT-3′ |
Reverse 5′-CTTGAGCAGCCACTCTTCTATG-3′ | |
Stat1 | Forward 5′-TCCATGCGGTTGAACCCTAC-3′ |
Reverse 5′-TGTCAGTGTTCTGTGCTCACTT-3′ | |
Mx1 | Forward 5′-GGTATCGTTACCAGGTGCCC-3′ |
Reverse 5′-GGTCTGGAACACTTGGGGAG-3′ | |
Ifng | Forward 5′-TGTTGCTCTGCCTCACTCAGG-3′ |
Reverse 5′-AAGACGAGGTCCCCTCCATTC-3′ | |
Actg1 | Forward 5′-ACAGAGAGAAGATGACGCAGATAATG-3′ |
Reverse 5′-GCCTGAATGGCCACGTACA-3′ | |
RdRp | Forward 5′-GTGARATGGTCATGTGTGGCGG-3′ |
Reverse 5′-CARATGTTAAASACACTATTAGCATA-3′ | |
Envelope (E) gene | Forward 5′-ACAGGTACGTTAATAGTTAATAGCGT-3′ |
Reverse 5′-ATATTGCAGCAGTACGCACACA-3′ | |
Probe FAM-ACACTAGCCATC-CTTACTGCGCTTCG-MGB | |
Cdkn2a (protein expression) | Forward 5′-TTTGAAGCTTGCCACCATGGAGCCCTCTGCGGAC-3′ |
Reverse 5′- TTTGGGATCCTTAGTAGGGCCCTAGGGGGTG -3′ | |